Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AX-8 in Patients With Chronic Cough
NCT04866563Phase 2Completed
- Sponsor
- Axalbion Therapeutics Limited
- Start
- Aug 2021
- Primary completion
- Jun 2025
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of ax-8 in chronic cough, sponsored by Axalbion Therapeutics Limited. Started Aug 2021; status: completed.
02
Drugs
ax-8
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT04866563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04866563.